Clara
- Manufacturer
- Handock Cosmetics Inc
- Effective date
- 2011-08-26
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:29:31
Label at a glance#
ProductClara
Active ingredientPSYLLIUM HUSK
Label structure8 sections
Label contents#
Full prescribing information#
active ingredient: psyllium husk powder, thistle
INACTIVE INGREDIENT SECTION
inactive ingredient: Inulin power, Indigestible maltodextrin, Kelp power, Lactulose power, Rice bran fermented power, Green tea power, L-Cystine, Propolis, Yeast Extract(B-glucan), Curcumd longa power, DL-methionine, Vitamix, Papain
OTC - PURPOSE SECTION
■ Enhances Liver function, detoxification and anti-inflammatory effects
■ Intestinal toxic emissions and health
■ Removes constipation and bad breadth
■ Dietary Fiber warranty
■ Enhances blood pressure and immune system
■ Diabetes prevention
■ Reduces Cholesterol
■ Prevention of adult diseases and osteoporosis
■ Removes Gastrointestinal Disorders and stomach gas
■ Intestinal toxic emissions and health
■ Removes constipation and bad breadth
■ Dietary Fiber warranty
■ Enhances blood pressure and immune system
■ Diabetes prevention
■ Reduces Cholesterol
■ Prevention of adult diseases and osteoporosis
■ Removes Gastrointestinal Disorders and stomach gas
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
Take 1-2 pack(s) two times daily with a full glass of water, preferably before a meal
WARNINGS SECTION
■ If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before
use. Discontinue use and consult your doctor if any adverse reactions occur.
■ Please check the ingredients before taking if there are allergic or idiosyncratic symptoms
■ Do not take if the product of expiration date is expired
use. Discontinue use and consult your doctor if any adverse reactions occur.
■ Please check the ingredients before taking if there are allergic or idiosyncratic symptoms
■ Do not take if the product of expiration date is expired
DOSAGE & ADMINISTRATION SECTION
■ After taking, first one or two weeks, stomach may feel uncomfortable due to nutritive functions. After that, should be oka
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 13620a32-e3b4-4aad-8280-283dce30ddff | Product name | 1 | 20260105 |
| 27883b46-af31-44b0-b4ce-e6b4f6d825a7 | Product name | 4 | 20250812 |
| c1a80c95-0e51-52a0-75fa-75808f51ded8 | Product name | 2 | 20150421 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76369-1001-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d664-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76369-1001-1 | Clara | 5 g in 1 PACKET | GRANULE | 5 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76369-1001 | CLARA (PSYLLIUM HUSK) GRANULE [HANDOCK COSMETICS INC] | 1 | Legacy NDC, 1 package rows | 20110913_f8a0faa0-985a-43ca-b253-348de058fa83.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PSYLLIUM HUSK | ACTIVE INGREDIENT | 0SHO53407G | 1 | |
| PSYLLIUM HUSK | ACTIVE MOIETY | 0SHO53407G | 1 | |
| CYSTINE | INACTIVE INGREDIENT | 48TCX9A1VT | 1 | |
| INULIN | INACTIVE INGREDIENT | JOS53KRJ01 | 1 | |
| KELP BASS | INACTIVE INGREDIENT | 24ZZ99M3KV | 1 | |
| lactulose | INACTIVE INGREDIENT | 9U7D5QH5AE | 1 | |
| MALTODEXTRIN | INACTIVE INGREDIENT | 7CVR7L4A2D | 1 | |
| PROPOLIS WAX | INACTIVE INGREDIENT | 6Y8XYV2NOF | 1 | |
| RICE | INACTIVE INGREDIENT | 659G217HPG | 1 | |
| TEA LEAF | INACTIVE INGREDIENT | GH42T47V24 | 1 |
Products#
Every source-derived product name is available through these pages.
- Clara
- PSYLLIUM HUSK
- INULIN
- MALTODEXTRIN
- KELP BASS
- lactulose
- RICE
- TEA LEAF
- CYSTINE
- PROPOLIS WAX
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76369-1001 | 76369-1001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PSYLLIUM HUSK | 0SHO53407G | ACTIB |
| INULIN | JOS53KRJ01 | IACT |
| MALTODEXTRIN | 7CVR7L4A2D | IACT |
| KELP BASS | 24ZZ99M3KV | IACT |
| lactulose | 9U7D5QH5AE | IACT |
| RICE | 659G217HPG | IACT |
| TEA LEAF | GH42T47V24 | IACT |
| CYSTINE | 48TCX9A1VT | IACT |
| PROPOLIS WAX | 6Y8XYV2NOF | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | SOLUTION / ORAL | 1451 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, CHEWABLE / ORAL | 292 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | PASTE / ORAL | 1050 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | NA | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | SUSPENSION / ORAL | 6040 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | LOZENGE / ORAL | 175 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, COATED / ORAL | 5.6 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | POWDER, FOR SUSPENSION / ORAL | 8000 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EXTENDED RELEASE / ORAL | 3239 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | GRANULE, FOR SUSPENSION / ORAL | 952 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | CAPSULE / ORAL | 200 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET, EFFERVESCENT / ORAL | 14404 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | FILM, SOLUBLE / ORAL | 19 mg | ||
| MALTODEXTRIN | MALTODEXTRIN | 7CVR7L4A2D | TABLET / ORAL | 320 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b2ca2351-0c83-4085-b2d7-4f775d4dbf38 | f8a0faa0-985a-43ca-b253-348de058fa83 | 2011-08-26 | Warnings | b2ca2351-0c83-4085-b2d7-4f775d4dbf38 f8a0faa0-985a-43ca-b253-348de058fa83 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
